Primary Site >> Stomach Cancer

Gene >> SPINK1

Journal: Int J Pancreatol. 1988 Jul;3(5):323-31.
Title: The measurement of serum immunoreactive pancreatic secretory trypsin inhibitor in gastrointestinal cancer and pancreatic disease.
Author: Satake, K|Inui, A|Sogabe, T|Yoshii, Y|Nakata, B|Tanaka, H|Chung, Y S|Hiura, A|Umeyama, K
PMID: 2459273
Journal: Minerva Med. 1989 Mar;80(3):199-203.
Title: [Determination of tumor-associated trypsin inhibitor (TATI) in subjects with gastrointestinal diseases. Preliminary data].
Author: Piantino, P|Mosso, R|Polloni, R|Cerchier, A|Gennaretti, G|Daziano, E
PMID: 2717042
Journal: Am J Clin Pathol. 1990 Jan;93(1):8-13.
Title: Immunohistochemical study on pancreatic secretory trypsin inhibitor (PSTI) in gastric carcinomas.
Author: Higashiyama, M|Monden, T|Ogawa, M|Matsuura, N|Murotani, M|Kawasaki, Y|Tomita, N|Murata, A|Shimano, T|Mori, T
PMID: 2403744
Journal: Scand J Clin Lab Invest Suppl. 1991;207:59-62.
Title: Tumor-associated trypsin inhibitor (TATI) in benign and malignant gastric disease.
Author: Loizate Toricaguena, A|Lamiquiz Vallejo, A|Dominguez Merru-Urrutia, M J|Legorburu Escudero, J F
PMID: 1780694
Journal: Scand J Clin Lab Invest Suppl. 1991;207:67-9.
Title: Tumor-associated trypsin inhibitor, TATI, in gastrointestinal cancer and related benign diseases.
Author: Piantino, P|Arosaio, E
PMID: 1780697
Journal: Eur J Surg Oncol. 1992 Apr;18(2):135-41.
Title: Hyperamylasemia associated with lymphadenectomy in patients surgically treated for gastric cancer.
Author: Korenaga, D|Watanabe, A|Baba, H|Saito, A|Maehara, Y|Sugimachi, K
PMID: 1374723
Journal: Int J Cancer. 1993 Nov 11;55(5):728-34.
Title: Specific expression of the pancreatic-secretory-trypsin-inhibitor (PSTI) gene in hepatocellular carcinoma.
Author: Ohmachi, Y|Murata, A|Matsuura, N|Yasuda, T|Yasuda, T|Monden, M|Mori, T|Ogawa, M|Matsubara, K
PMID: 8244568
Journal: J Med Screen. 1994 Jan;1(1):60-4.
Title: Tumour markers and screening for gastrointestinal cancer: a follow up study in Finland.
Author: Hakama, M|Stenman, U H|Knekt, P|Jarvisalo, J|Leino, A|Hakulinen, T|Maatela, J|Aromaa, A
PMID: 8790487
Journal: Int J Colorectal Dis. 2002 Sep;17(5):338-43. Epub 2002 Jan 23.
Title: Genetic polymorphisms of cytochrome p450 2E1, glutathione S-transferase M1 and T1, and susceptibility to gastric carcinoma in Taiwan.
Author: Wu, Ming-Shiang|Chen, Chien-Jen|Lin, Ming-Tsan|Wang, Hsiu-Po|Shun, Chia-Tung|Sheu, Jin-Chuan|Lin, Jaw-Town
PMID: 12172927
Journal: J Gastroenterol Hepatol. 2003 Nov;18(11):1257-63.
Title: Analysis of CYP2E1 polymorphism for the determination of genetic susceptibility to gastric cancer in Koreans.
Author: Park, Geun Tae|Lee, Oh Young|Kwon, Sung Joon|Lee, Chun Geun|Yoon, Byung Chul|Hahm, Joon Soo|Lee, Min Ho|Hoo Lee, Dong|Kee, Choon Suhk|Sun, Hee Sik
PMID: 14535982
Journal: Histopathology. 2005 Apr;46(4):380-8.
Title: High tissue expression of tumour-associated trypsin inhibitor (TATI) associates with a more favourable prognosis in gastric cancer.
Author: Wiksten, J-P|Lundin, J|Nordling, S|Kokkola, A|Stenman, U-H|Haglund, C
PMID: 15810949
Journal: Anticancer Res. 2008 Jul-Aug;28(4C):2279-87.
Title: Comparison of the prognostic value of a panel of tissue tumor markers and established clinicopathological factors in patients with gastric cancer.
Author: Wiksten, Jan-Patrik|Lundin, Johan|Nordling, Stig|Kokkola, Arto|Haglund, Caj
PMID: 18751407
Journal: Dig Dis Sci. 2009 Jan;54(1):70-4.
Title: Protective role of genetic polymorphism of heat shock protein 70-2 for gastric cancer risk.
Author: Shibata, Tomoyuki|Arisawa, Tomiyasu|Tahara, Tomomitsu|Yoshioka, Daisuke|Maruyama, Naoko|Fujita, Hiroshi|Kamiya, Yoshio|Nakamura, Masakatsu|Nagasaka, Mitsuo|Iwata, Masami|Takahama, Kazuya|Watanabe, Makoto|Hirata, Ichiro|Nakano, Hiroshi
PMID: 18478330
Journal: PLoS One. 2012;7(9):e44478.
Title: Functional PstI/RsaI polymorphism in CYP2E1 is associated with the development, progression and poor outcome of gastric cancer.
Author: Feng, Jin|Pan, Xiaolin|Yu, Junbo|Chen, Zheng|Xu, Hao|El-Rifai, Wael|Zhang, Guoxin|Xu, Zekuan
PMID: 22957075
Journal: Exp Ther Med. 2012 Jan;3(1):109-116.
Title: Development of a survival prediction model for gastric cancer using serine proteases and their inhibitors.
Author: Lei, Ke-Feng|Liu, Bing-Ya|Zhang, Xiao-Qing|Jin, Xiao-Long|Guo, Yan|Ye, Min|Zhu, Zheng-Gang
PMID: 22969854
Journal: PLoS One. 2012;7(11):e48265.
Title: CYP2E1 RsaI/PstI polymorphism and gastric cancer susceptibility: meta-analyses based on 24 case-control studies.
Author: Zhuo, Wenlei|Zhang, Liang|Wang, Yan|Ling, Junjun|Zhu, Bo|Chen, Zhengtang
PMID: 23139769
Journal: Eur Rev Med Pharmacol Sci. 2013 Nov;17(21):2923-8.
Title: The relationship between serum tumor-associated trypsin inhibitor levels and clinicopathological parameters in patients with gastric cancer.
Author: Kemik, O|Kemik, A|Sumer, A|Almali, N|Gurluler, E|Gures, N|Purisa, S|Adas, G|Dogan, Y|Tuzun, S
PMID: 24254562
Journal: Mol Clin Oncol. 2016 Jun;4(6):1031-1038.
Title: Association between CYP2E1 polymorphisms and risk of gastric cancer: An updated meta-analysis of 32 case-control studies.
Author: Zhang, Ming-Xing|Liu, Kai|Wang, Fu-Gang|Wen, Xiao-Wen|Song, Xi-Lin
PMID: 27284439